General Information of Drug (ID: DM7K2TG)

Drug Name
StarGen Stargardt's disease gene therapy
Indication
Disease Entry ICD 11 Status REF
Stargardt disease 9B70 Phase 1/2 [1]
Cross-matching ID
TTD ID
D0F7QP

References

1 ClinicalTrials.gov (NCT01367444) Phase I/IIa Study of StarGen in Patients With Stargardt's Macular Degeneration. U.S. National Institutes of Health.